FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129478081> ?p ?o ?g. }

• W2129478081 endingPage "478" @default.
• W2129478081 startingPage "474" @default.
• W2129478081 abstract "Eicosapentaenoic acid (EPA) possesses a variety of pharmacologic actions and demonstrates protective efficacy against stroke. Meanwhile, asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor and is thereby considered one of the risk factors of cardiovascular disease. The effects of the EPA treatment on ADMA in patients in the chronic phase of cerebral infarction accompanied by dyslipidemia were investigated.Study subjects were individuals with either atherothrombotic or lacunar cerebral infarction in the chronic phase accompanied by dyslipidemia, of which the onset was at least 4 weeks earlier. Lipid, fatty acid, and ADMA levels in the blood were measured at EPA 1800 mg per day and compared both before and after treatment. Twenty subjects were included in the study (average age, 71.9 ± 8.9 years).Of these 20 cases, eight were atherothrombotic and 12 were lacunar. Moreover, 17 cases were accompanied by hypertension and 10 cases were accompanied by diabetes mellitus. After EPA treatment (average duration of treatment, 143 ± 42 days), EPA increased from 65.1 ± 38.1 μg/mL to 201.1 ± 73.4 μg/mL (P < .01). Arachidonic acid (AA) decreased from 149.1 ± 34.8 μg/mL to 129.7 ± 22.3 μg/mL (P < .01), and the EPA/AA ratio increased from 0.45 ± 0.26 to 1.55 ± 0.46 (P < .01). ADMA decreased from 0.49 ± 0.07 nmol/mL before treatment to 0.46 ± 0.05 nmol/mL after treatment (P < .01).EPA treatment in patients in the chronic phase of cerebral infarction leads to a decrease in ADMA in the blood, suggesting that EPA improves vascular endothelial function and therefore supports the protective efficacy against cerebral infarction." @default.
• W2129478081 created "2016-06-24" @default.
• W2129478081 creator A5032520963 @default.
• W2129478081 creator A5054459673 @default.
• W2129478081 creator A5068252088 @default.
• W2129478081 date "2011-09-01" @default.
• W2129478081 modified "2023-10-16" @default.
• W2129478081 title "Effects of Eicosapentaenoic Acid on Asymmetric Dimethylarginine in Patients in the Chronic Phase of Cerebral Infarction: A Preliminary Study" @default.
• W2129478081 cites W104265187 @default.
• W2129478081 cites W1572120598 @default.
• W2129478081 cites W1965070554 @default.
• W2129478081 cites W1969693351 @default.
• W2129478081 cites W1974205400 @default.
• W2129478081 cites W1981268963 @default.
• W2129478081 cites W2002210634 @default.
• W2129478081 cites W2010079762 @default.
• W2129478081 cites W2012128727 @default.
• W2129478081 cites W2014696483 @default.
• W2129478081 cites W2016306174 @default.
• W2129478081 cites W2019262320 @default.
• W2129478081 cites W2037655806 @default.
• W2129478081 cites W2044390537 @default.
• W2129478081 cites W2058385357 @default.
• W2129478081 cites W2066465207 @default.
• W2129478081 cites W2068717153 @default.
• W2129478081 cites W2072531665 @default.
• W2129478081 cites W2074702732 @default.
• W2129478081 cites W2083441169 @default.
• W2129478081 cites W2090170448 @default.
• W2129478081 cites W2090744550 @default.
• W2129478081 cites W2096617951 @default.
• W2129478081 cites W2099988883 @default.
• W2129478081 cites W2114344280 @default.
• W2129478081 cites W2140179588 @default.
• W2129478081 cites W2142347023 @default.
• W2129478081 cites W2162752850 @default.
• W2129478081 cites W2166912566 @default.
• W2129478081 cites W2166937516 @default.
• W2129478081 cites W2169002600 @default.
• W2129478081 cites W2170750989 @default.
• W2129478081 cites W4255275935 @default.
• W2129478081 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.12.006" @default.
• W2129478081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21277225" @default.
• W2129478081 hasPublicationYear "2011" @default.
• W2129478081 type Work @default.
• W2129478081 sameAs 2129478081 @default.
• W2129478081 citedByCount "12" @default.
• W2129478081 countsByYear W21294780812015 @default.
• W2129478081 countsByYear W21294780812016 @default.
• W2129478081 countsByYear W21294780812017 @default.
• W2129478081 countsByYear W21294780812019 @default.
• W2129478081 countsByYear W21294780812020 @default.
• W2129478081 crossrefType "journal-article" @default.
• W2129478081 hasAuthorship W2129478081A5032520963 @default.
• W2129478081 hasAuthorship W2129478081A5054459673 @default.
• W2129478081 hasAuthorship W2129478081A5068252088 @default.
• W2129478081 hasConcept C126322002 @default.
• W2129478081 hasConcept C134018914 @default.
• W2129478081 hasConcept C181199279 @default.
• W2129478081 hasConcept C185592680 @default.
• W2129478081 hasConcept C19038510 @default.
• W2129478081 hasConcept C2776091944 @default.
• W2129478081 hasConcept C2777468819 @default.
• W2129478081 hasConcept C2778078955 @default.
• W2129478081 hasConcept C2778096610 @default.
• W2129478081 hasConcept C2779450755 @default.
• W2129478081 hasConcept C2779877776 @default.
• W2129478081 hasConcept C515207424 @default.
• W2129478081 hasConcept C541997718 @default.
• W2129478081 hasConcept C543025807 @default.
• W2129478081 hasConcept C55493867 @default.
• W2129478081 hasConcept C555293320 @default.
• W2129478081 hasConcept C71924100 @default.
• W2129478081 hasConcept C90924648 @default.
• W2129478081 hasConceptScore W2129478081C126322002 @default.
• W2129478081 hasConceptScore W2129478081C134018914 @default.
• W2129478081 hasConceptScore W2129478081C181199279 @default.
• W2129478081 hasConceptScore W2129478081C185592680 @default.
• W2129478081 hasConceptScore W2129478081C19038510 @default.
• W2129478081 hasConceptScore W2129478081C2776091944 @default.
• W2129478081 hasConceptScore W2129478081C2777468819 @default.
• W2129478081 hasConceptScore W2129478081C2778078955 @default.
• W2129478081 hasConceptScore W2129478081C2778096610 @default.
• W2129478081 hasConceptScore W2129478081C2779450755 @default.
• W2129478081 hasConceptScore W2129478081C2779877776 @default.
• W2129478081 hasConceptScore W2129478081C515207424 @default.
• W2129478081 hasConceptScore W2129478081C541997718 @default.
• W2129478081 hasConceptScore W2129478081C543025807 @default.
• W2129478081 hasConceptScore W2129478081C55493867 @default.
• W2129478081 hasConceptScore W2129478081C555293320 @default.
• W2129478081 hasConceptScore W2129478081C71924100 @default.
• W2129478081 hasConceptScore W2129478081C90924648 @default.
• W2129478081 hasIssue "5" @default.
• W2129478081 hasLocation W21294780811 @default.
• W2129478081 hasLocation W21294780812 @default.
• W2129478081 hasOpenAccess W2129478081 @default.
• W2129478081 hasPrimaryLocation W21294780811 @default.
• W2129478081 hasRelatedWork W1966504330 @default.

• next